{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:37:56Z","timestamp":1790645876311,"version":"4.1.0"},"reference-count":54,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Substitution of valine (Val) for aspartic acid (Asp) at codon 814 constitutively activates murine c-kit receptor tyrosine kinase (KIT), and Asp816Val mutation, corresponding to murine Asp814Val mutation, is found in patients with mastocytosis and acute myelocytic leukemia. However, the signal transduction pathways responsible for oncogenesis by the Asp814Val mutant (KITVal814) are not fully understood. To examine the oncogenic signal transduction of KITVal814, we converted 20 tyrosine (Tyr) residues to phenylalanine (Phe) in the cytoplasmic domain of KITVal814 or deleted the C-terminal region containing 2 other tyrosine residues (Del). Among various KITVal814- derived mutants, KITVal814-Tyr719Phe and KITVal814-Delseverely impaired receptor tyrosine phosphorylation and association with the p85 subunit of phosphatidylinositol 3\u2032-kinase (p85PI3-K). Moreover, KITVal814-Tyr719Pheand KITVal814-Del failed to induce ligand-independent growth in Ba\/F3 cells, indicating that Tyr719, the binding site for p85PI3-K, and the C-terminal region are indispensable for factor-independent growth by KITVal814. Although the C-terminal region was also required for ligand-dependent growth by wild-type KIT (KITWT), the Tyr719Phe substitution had negligible effects on ligand-dependent growth by KITWT. Furthermore, dominant-negative PI3-K significantly inhibited ligand-independent growth by KITVal814. These results demonstrate that Tyr719 is crucial for constitutive activation of KITVal814, but not for the ligand-induced activation of KITWT, and that the downstream signaling of PI3-K plays an important role in ligand-independent growth and tumorigenicity by KITVal814, thereby suggesting that KITVal814 is a unique activating mutation that leads to a distinguishable function from the effects of KITWT.<\/jats:p>","DOI":"10.1182\/blood-2002-01-0177","type":"journal-article","created":{"date-parts":[[2003,1,15]],"date-time":"2003-01-15T21:05:10Z","timestamp":1042664710000},"page":"1094-1102","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":41,"title":["Necessity of tyrosine 719 and phosphatidylinositol 3\u2032-kinase\u2013mediated signal pathway in constitutive activation and oncogenic potential of c-kit receptor tyrosine kinase with the Asp814Val mutation"],"prefix":"10.1182","volume":"101","author":[{"given":"Koji","family":"Hashimoto","sequence":"first","affiliation":[{"name":"From the Department of Pathology and the Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita; and the Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Matsumura","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and the Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita; and the Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Tsujimura","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and the Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita; and the Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Ki","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and the Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita; and the Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ogihara","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and the Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita; and the Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Ikeda","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and the Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita; and the Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Ueda","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and the Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita; and the Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Mizuki","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and the Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita; and the Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Sugahara","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and the Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita; and the Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohiko","family":"Shibayama","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and the Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita; and the Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Kitamura","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and the Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita; and the Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzuru","family":"Kanakura","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and the Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita; and the Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111612341339900_B1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/j.1460-2075.1988.tb02907.x","article-title":"Primary structure of c-kit: relationship with the CSF-1\/PDGF receptor kinase family\u2014oncogenic activation of v-kit involves deletion of extracellular domain and C terminus.","volume":"7","author":"Qiu","year":"1988","journal-title":"EMBO J."},{"key":"2019111612341339900_B2","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1002\/j.1460-2075.1987.tb02655.x","article-title":"Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.","volume":"6","author":"Yarden","year":"1987","journal-title":"EMBO J."},{"key":"2019111612341339900_B3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.bi.62.070193.002321","article-title":"Signalling by receptor tyrosine kinases.","volume":"62","author":"Fantl","year":"1993","journal-title":"Annu Rev Biochem."},{"key":"2019111612341339900_B4","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/j.1460-2075.1991.tb07784.x","article-title":"Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase.","volume":"10","author":"Reith","year":"1991","journal-title":"EMBO J."},{"key":"2019111612341339900_B5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(90)90801-K","article-title":"Signal transduction by receptors with tyrosine kinase activity.","volume":"61","author":"Ullrich","year":"1990","journal-title":"Cell."},{"key":"2019111612341339900_B6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.bi.57.070188.002303","article-title":"Growth factor receptor tyrosine kinases.","volume":"57","author":"Yarden","year":"1988","journal-title":"Annu Rev Biochem."},{"key":"2019111612341339900_B7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(90)90299-T","article-title":"The kit ligand: a cell surface molecule altered in steel mutant fibroblasts.","volume":"63","author":"Flanagan","year":"1990","journal-title":"Cell."},{"key":"2019111612341339900_B8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0092-8674(90)90303-V","article-title":"The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus.","volume":"63","author":"Huang","year":"1990","journal-title":"Cell."},{"key":"2019111612341339900_B9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0092-8674(90)90297-R","article-title":"Identification of a ligand for the c-kit proto-oncogene.","volume":"63","author":"Williams","year":"1990","journal-title":"Cell."},{"key":"2019111612341339900_B10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0092-8674(90)90302-U","article-title":"Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor.","volume":"63","author":"Zsebo","year":"1990","journal-title":"Cell."},{"key":"2019111612341339900_B11","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1128\/MCB.11.6.3043","article-title":"The Steel\/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor.","volume":"11","author":"Rottapel","year":"1991","journal-title":"Mol Cell Biol."},{"key":"2019111612341339900_B12","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.1016\/S0021-9258(17)37564-6","article-title":"Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit\u2013associated PI 3-kinase activity in COS-1 cells.","volume":"269","author":"Serve","year":"1994","journal-title":"J Biol Chem."},{"key":"2019111612341339900_B13","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1128\/MCB.13.6.3350","article-title":"Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand.","volume":"13","author":"Yi","year":"1993","journal-title":"Mol Cell Biol."},{"key":"2019111612341339900_B14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1073\/pnas.89.2.678","article-title":"Interkinase domain of kit contains the binding site for phosphatidylinositol 3\u2032 kinase.","volume":"89","author":"Lev","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111612341339900_B15","doi-asserted-by":"crossref","first-page":"16965","DOI":"10.1074\/jbc.274.24.16965","article-title":"STAT protein recruitment and activation in c-Kit deletion mutants.","volume":"274","author":"Brizzi","year":"1999","journal-title":"J Biol Chem."},{"key":"2019111612341339900_B16","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.","volume":"92","author":"Furitsu","year":"1993","journal-title":"J Clin Invest."},{"key":"2019111612341339900_B17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000236870","article-title":"Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3.","volume":"106","author":"Tsujimura","year":"1995","journal-title":"Int Arch Allergy Immunol."},{"key":"2019111612341339900_B18","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood.V83.9.2619.2619","article-title":"Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation.","volume":"83","author":"Tsujimura","year":"1994","journal-title":"Blood."},{"key":"2019111612341339900_B19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood.V87.1.273.273","article-title":"Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain.","volume":"87","author":"Tsujimura","year":"1996","journal-title":"Blood."},{"key":"2019111612341339900_B20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V85.3.790.bloodjournal853790","article-title":"Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.","volume":"85","author":"Kitayama","year":"1995","journal-title":"Blood."},{"key":"2019111612341339900_B21","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood.V88.3.995.995","article-title":"Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase.","volume":"88","author":"Kitayama","year":"1996","journal-title":"Blood."},{"key":"2019111612341339900_B22","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood.V93.4.1319","article-title":"Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site.","volume":"93","author":"Tsujimura","year":"1999","journal-title":"Blood."},{"key":"2019111612341339900_B23","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111612341339900_B24","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1182\/blood.V90.11.4539","article-title":"Expression of constitutively activated human c-Kit in Myb-transformed early myeloid cells leads to factor independence, histiocytic differentiation, and tumorigenicity.","volume":"90","author":"Ferrao","year":"1997","journal-title":"Blood."},{"key":"2019111612341339900_B25","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111612341339900_B26","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1074\/jbc.271.7.3347","article-title":"Role of aspartic acid 814 in the function and expression of c-kit receptor tyrosine kinase.","volume":"271","author":"Moriyama","year":"1996","journal-title":"J Biol Chem."},{"key":"2019111612341339900_B27","doi-asserted-by":"crossref","first-page":"14665","DOI":"10.1073\/pnas.93.25.14665","article-title":"Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1.","volume":"93","author":"Piao","year":"1996","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111612341339900_B28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.174.1.63","article-title":"Expression and function of c-kit in hemopoietic progenitor cells.","volume":"174","author":"Ogawa","year":"1991","journal-title":"J Exp Med."},{"key":"2019111612341339900_B29","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1093\/nar\/18.17.5322","article-title":"pEF-BOS, a powerful mammalian expression vector.","volume":"18","author":"Mizushima","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"2019111612341339900_B30","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/j.1460-2075.1994.tb06515.x","article-title":"Involvement of phosphoinositide 3-kinase in insulin- or IGF-1\u2013induced membrane ruffling.","volume":"13","author":"Kotani","year":"1994","journal-title":"EMBO J."},{"key":"2019111612341339900_B31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5.","volume":"36","author":"Graham","year":"1977","journal-title":"J Gen Virol."},{"key":"2019111612341339900_B32","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.1093\/nar\/16.15.7351","article-title":"A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.","volume":"16","author":"Higuchi","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"2019111612341339900_B33","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1073\/pnas.76.3.1373","article-title":"DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.","volume":"76","author":"Wigler","year":"1979","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111612341339900_B34","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood.V76.4.706.706","article-title":"Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins.","volume":"76","author":"Kanakura","year":"1990","journal-title":"Blood."},{"key":"2019111612341339900_B35","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1128\/MCB.8.11.4896","article-title":"c-kit protein, a transmembrane kinase: identification in tissues and characterization.","volume":"8","author":"Majumder","year":"1988","journal-title":"Mol Cell Biol."},{"key":"2019111612341339900_B36","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V78.11.2834.2834","article-title":"Proliferation of human myeloid leukemia cell line associated with the tyrosine-phosphorylation and activation of the proto-oncogene c-kit product.","volume":"78","author":"Kuriu","year":"1991","journal-title":"Blood."},{"key":"2019111612341339900_B37","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1128\/MCB.18.7.4282","article-title":"Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.","volume":"18","author":"Matsumura","year":"1998","journal-title":"Mol Cell Biol."},{"key":"2019111612341339900_B38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood.V86.2.703.bloodjournal862703","article-title":"Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin.","volume":"86","author":"Matsumura","year":"1995","journal-title":"Blood."},{"key":"2019111612341339900_B39","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood.V99.5.1741","article-title":"The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors: kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations.","volume":"99","author":"Ma","year":"2002","journal-title":"Blood."},{"key":"2019111612341339900_B40"},{"key":"2019111612341339900_B41","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.V98.5.1365","article-title":"Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant.","volume":"98","author":"Chian","year":"2001","journal-title":"Blood."},{"key":"2019111612341339900_B42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/72814","article-title":"Kit\/stem cell factor receptor-induced activation of phosphatidylinositol 3\u2032-kinase is essential for male fertility.","volume":"24","author":"Blume-Jensen","year":"2000","journal-title":"Nat Genet."},{"key":"2019111612341339900_B43","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/emboj\/19.6.1312","article-title":"Point mutation in kit receptor tyrosine kinase reveals essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit responses.","volume":"19","author":"Kissel","year":"2000","journal-title":"EMBO J."},{"key":"2019111612341339900_B44","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1182\/blood.V99.5.1758","article-title":"TEL\/platelet-derived growth factor receptor beta activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycle.","volume":"99","author":"Dierov","year":"2002","journal-title":"Blood."},{"key":"2019111612341339900_B45","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1006\/bbrc.1999.1186","article-title":"Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signaling molecules mediated by ret with the MEN 2B mutation.","volume":"262","author":"Murakami","year":"1999","journal-title":"Biochem Biophys Res Commun."},{"key":"2019111612341339900_B46","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1074\/jbc.275.5.3568","article-title":"Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase\/AKT signaling pathway.","volume":"275","author":"Segouffin-Cariou","year":"2000","journal-title":"J Biol Chem."},{"key":"2019111612341339900_B47","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1093\/emboj\/16.20.6151","article-title":"Transformation of hematopoietic cells by BCR\/ABL requires activation of a PI-3k\/Akt\u2013 dependent pathway.","volume":"16","author":"Skorski","year":"1997","journal-title":"EMBO J."},{"key":"2019111612341339900_B48","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood.V97.11.3559","article-title":"Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit\u2013mediated cytokine-independent survival and proliferation in human leukemia cells.","volume":"97","author":"Ning","year":"2001","journal-title":"Blood."},{"key":"2019111612341339900_B49","first-page":"99","article-title":"Preferential inhibition of constitutive activating juxtamembrane mutant rather than kinase domain mutant and wild-type c-Kit receptor tyrosine kinase by tyrophostin [abstract].","volume":"96","author":"Ikeda","year":"2000","journal-title":"Blood."},{"key":"2019111612341339900_B50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(02)07679-1","article-title":"BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome\u2013positive leukaemia to STI571: a prospective study.","volume":"359","author":"von Bubnoff","year":"2002","journal-title":"Lancet."},{"key":"2019111612341339900_B51","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1074\/jbc.M107648200","article-title":"Phosphatidylinositol 3-kinase p85 adapter function in T-cells: co-stimulation and regulation of cytokine transcription independent of associated p110.","volume":"277","author":"Kang","year":"2002","journal-title":"J Biol Chem."},{"key":"2019111612341339900_B52","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/j.1460-2075.1995.tb07023.x","article-title":"Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells.","volume":"14","author":"Serve","year":"1995","journal-title":"EMBO J."},{"key":"2019111612341339900_B53","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1093\/emboj\/17.21.6250","article-title":"Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation.","volume":"17","author":"Timokhina","year":"1998","journal-title":"EMBO J."},{"key":"2019111612341339900_B54","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1182\/blood.V97.8.2434","article-title":"Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.","volume":"97","author":"Yamamoto","year":"2001","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/3\/1094\/1258396\/h80303001094.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/3\/1094\/1258396\/h80303001094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T09:22:43Z","timestamp":1622020963000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/3\/1094\/88819\/Necessity-of-tyrosine-719-and-phosphatidylinositol"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,1]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,2,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-01-0177","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2,1]]}}}